Pharma company BioMarin is expanding its manufacturing base in Cork. The high-tech life sciences company is growing its facility in Shanbally to allow for the manufacture of medicines for the treatment of Rare Genetic Diseases, mostly in children.
BioMarin recently extended its footprint to 20 acres at the existing site. The company continues to experience a rise in the global demand for its therapies.
Since opening here in 2011, Biomarin has grown to 365 employees in Cork, with an additional 67 people based in Dublin and 2,400 employees globally. The expansion project began two years ago to cater for continued growth at the site and includes an expanded warehouse, new administration and utility offices, a canteen and conference facilities, which will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity.
Speaking at the announcement, Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin stated, “Ireland has proved to be an ideal location to expand our operations. The team at Shanbally has enabled us to accommodate our growing commercial portfolio and advancing clinical programs. Mostly children, our patients suffer from diseases so rare that the entire afflicted population may number as few as 1,000 worldwide. Often inherited, difficult to diagnose, and progressively debilitating, these conditions have, up until now, been largely ignored. As we continue to grow in Shanbally, we are looking to recruit the best and brightest in a variety of disciplines to help us continue our inspiring work for patients.”
Information about open positions at BioMarin is available here.
Find out more about career opportunities the life sciences and pharma sector in Ireland.
The CareersPortal Team